Cargando…
Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution
Although post-operative adjuvant chemotherapy (ACT) is only recommended for patients with stage II colon cancer who are at a high risk of recurrence, the definition of high risk remains unclear. The present study aimed to identify the risk factors for recurrence, which may also be indicators for adj...
Autores principales: | YAMAGUCHI, KEIZO, OGATA, YUTAKA, AKAGI, YOSHITO, SHIROUZU, KAZUO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789105/ https://www.ncbi.nlm.nih.gov/pubmed/24137386 http://dx.doi.org/10.3892/ol.2013.1433 |
Ejemplares similares
-
Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
por: Akagi, Yoshito, et al.
Publicado: (2013) -
Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal Cancer
por: Ogata, Yutaka, et al.
Publicado: (2015) -
Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells
por: USHIJIMA, MASATAKA, et al.
Publicado: (2014) -
Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer
por: Ogata, Yutaka, et al.
Publicado: (2013) -
Intersphincteric resection for very low rectal cancer: A review of the updated literature
por: Shirouzu, Kazuo, et al.
Publicado: (2017)